Stockreport

Intellia Therapeutics Inc (NTLA) Q3 2024 Earnings Call Highlights: Financial Stability and ... [Yahoo! Finance]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF Collaboration Revenue: $9.1 million during Q3 2024, down from $12 million in Q3 2023. R&D Expenses: $123.4 million during Q3 2024, up from $113.7 million in Q3 2023. [Read more]